#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Krabbe's disease Adrenoleukodystrophy Autoimmune myositis Interstitial lung disease NTRK gene fusion overexpression Pleural mesothelioma Selective polysaccharide antibody deficiency Duchenne muscular dystrophy gene carrier Chronic myelomonocytic leukaemia Cervix carcinoma recurrent Plasma cell myeloma recurrent Cystic fibrosis Mantle cell lymphoma Chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Life with Disease Glomerulonephritis membranoproliferative – Basic Information Uterine leiomyosarcoma – Basic Information Haemophilia B without inhibitors – Basic Information Hereditary neuropathic amyloidosis – Treatment Thrombotic thrombocytopenic purpura – Life with Disease Primary hyperoxaluria – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Pleural mesothelioma malignant Marginal zone lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Maribavir Bisoprolol Iohexol Lasmiditan Buspirone Hydrochloride Cloxacillin 177Lu-Dpi-4452 Aceclofenac Emtricitabine VERT-002 Dantrolene Sodium D-Biotin GSKVX000000017986 Calcipotriol Ecoo75 Iloprost Trometamol Ertapenem Ethambutol Izorlisib Mesilate Adrenaline Tartrate Ph. Eur. More therapies…

    Learn about Your Condition

    Synovial sarcoma recurrent Corneal dystrophy Hypertonic bladder Psoriatic arthropathy PIK3CA-activated mutation Osteosarcoma recurrent Adrenogenital syndrome Corticobasal degeneration Breast cancer stage I Vulvovaginal discomfort Diabetic foot Myeloproliferative neoplasm Cardiac failure congestive Vulvovaginal pruritus Hairy cell leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • VOROLANIB
    • Aflibercept
    Czechia Germany Hungary

  • Study of semaglutide to reduce cannabis use in adults with cannabis use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Semaglutide
    • Sodium Chloride
    Denmark

  • Comparing AZD5335 with Mirvetuximab Soravtansine or a drug combination in patients with platinum-resistant ovarian cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • AZD5335
    • Doxorubicin Hydrochloride, Liposomal
    Belgium Czechia Denmark France Germany Greece +4

  • A study to investigate the safety and effects of ceralasertib, tremelimumab, and durvalumab in adults with various solid tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Tremelimumab
    • Hyaluronidase (Human Recombinant)
    • Durvalumab
    Poland

  • A study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • LY3841136 SODIUM
    Belgium Germany Poland

  • A study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Bulgaria Poland
Previous Page
1 … 36 37 38 39 40 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!